A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker (Q85932400)
Jump to navigation
Jump to search
scientific article published on 22 January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker |
scientific article published on 22 January 2013 |
Statements
A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker (English)
Masahiro Hirakawa
Yasushi Sato
Hiroyuki Ohnuma
Tetsuji Takayama
Tamotsu Sagawa
Takayuki Nobuoka
Keisuke Harada
Hiroshi Miyamoto
Yasuhiro Sato
Yasuo Takahashi
Shinich Katsuki
Michiaki Hirayama
Minoru Takahashi
Masahiro Maeda
Kohichi Takada
Tsuyoshi Hayashi
Tsutomu Sato
Rishu Takimoto
Masayoshi Kobune
Koichi Hirata
22 January 2013